Ogimoto Masaro, Anzai Keizo, Takenoshita Hiromasa, Kogawa Kazuhiko, Akehi Yuko, Yoshida Ryoko, Nakano Makiko, Yoshida Kunihiro, Ono Junko
Department of Endocrinology and Diabetes, Fukuoka University School of Medicine, Japan.
Intern Med. 2011;50(13):1415-8. doi: 10.2169/internalmedicine.50.5108. Epub 2011 Jul 1.
A 52-year-old Japanese woman being treated for type 1 diabetes showed forgetfulness and microcytic anemia with a high serum ferritin concentration. Serum and brain radiological examinations revealed aceruloplasminemia, which was confirmed by genetic testing. Aceruloplasminemia is characterized by the triad of retinal degeneration, diabetes mellitus, and adult-onset disorder of the extrapyramidal system. Though physicians should treat such patients earlier, it is difficult to diagnose the disease before the presentation of neurological symptoms. Despite the presence of microcytic anemia, aceruloplasminemia patients usually have a high serum ferritin concentration due to the complete absence of ceruloplasmin ferroxidase activity. Thus, physicians should consider aceruloplasminemia when diabetic patients present with microcytic anemia and a high serum ferritin concentration.
一名正在接受1型糖尿病治疗的52岁日本女性出现健忘和小细胞性贫血,血清铁蛋白浓度升高。血清和脑部影像学检查显示无铜蓝蛋白血症,基因检测证实了这一诊断。无铜蓝蛋白血症的特征为视网膜变性、糖尿病和成人期锥体外系疾病三联征。尽管医生应尽早治疗此类患者,但在出现神经症状之前很难诊断该病。尽管存在小细胞性贫血,但由于完全缺乏铜蓝蛋白铁氧化酶活性,无铜蓝蛋白血症患者的血清铁蛋白浓度通常较高。因此,当糖尿病患者出现小细胞性贫血和高血清铁蛋白浓度时,医生应考虑无铜蓝蛋白血症。